We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Oppenheimer Holdings
OPY
$1.22B
| $333K | ﹤0.01% |
14,204
+700
| +5% | +$15.2K |
|
2552
Supernus Pharmaceuticals
SUPN
$2.72B
| $331K | ﹤0.01% |
27,342
+4,800
| +21% | +$45.4K |
|
|
BV
2553
DELISTED
Bazaarvoice, Inc.
BV
| $331K | ﹤0.01% |
58,516
+4,600
| +9% | +$35.4K |
|
|
PTX
2554
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $331K | ﹤0.01% |
3,092
+470
| +18% | +$44.8K |
|
2555
Clarus
CLAR
$130M
| $330K | ﹤0.01% |
35,023
+4,018
| +13% | +$30.1K |
|
2556
Alto Ingredients
ALTO
$349M
| $329K | ﹤0.01% |
30,527
+500
| +2% | +$4.81K |
|
2557
RELX
RELX
$62.4B
| $329K | ﹤0.01% |
19,092
+1,452
| +8% | +$25.2K |
|
|
PTVCB
2558
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $329K | ﹤0.01% |
14,010
+600
| +4% | +$14.3K |
|
|
MRGE
2559
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $329K | ﹤0.01% |
73,609
+13,300
| +22% | +$55.5K |
|
|
IMMU
2560
DELISTED
Immunomedics Inc
IMMU
| $328K | ﹤0.01% |
85,643
+14,700
| +21% | +$63.9K |
|
|
NATL
2561
DELISTED
National Interstate Corporation
NATL
| $328K | ﹤0.01% |
11,680
+700
| +6% | +$19.1K |
|
2562
Clear Channel Outdoor Holdings
CCO
$1.23B
| $327K | ﹤0.01% |
32,324
+3,590
| +12% | +$34.9K |
|
|
LXFT
2563
DELISTED
Luxoft Holding, Inc.
LXFT
| $327K | ﹤0.01% |
6,314
+920
| +17% | +$41.9K |
|
|
FRM
2564
DELISTED
FURMANITE CORPORATION COM
FRM
| $327K | ﹤0.01% |
41,425
+7,100
| +21% | +$53.1K |
|
2565
Builders FirstSource
BLDR
$7.8B
| $326K | ﹤0.01% |
48,846
+8,950
| +22% | +$55.9K |
|
|
TTSH
2566
DELISTED
Tile Shop Holdings
TTSH
| $326K | ﹤0.01% |
26,882
+5,300
| +25% | +$51.7K |
|
|
DCM
2567
DELISTED
NTT DOCOMO, Inc.
DCM
| $326K | ﹤0.01% |
18,710
+1,640
| +10% | +$28.2K |
|
2568
CNB Financial Corp
CCNE
$1.04B
| $325K | ﹤0.01% |
19,120
+1,000
| +6% | +$17.3K |
|
|
ARMH
2569
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $325K | ﹤0.01% |
6,589
+89
| +1% | +$4.43K |
|
2570
Reading International Class A
RDI
$35.2M
| $323K | ﹤0.01% |
24,019
+1,200
| +5% | +$15.3K |
|
|
VWR
2571
DELISTED
VWR Corporation
VWR
| $323K | ﹤0.01% |
12,410
+4,070
| +49% | +$101K |
|
|
ELRC
2572
DELISTED
ELECTRO RENT CORP
ELRC
| $322K | ﹤0.01% |
28,415
+1,200
| +4% | +$14.7K |
|
|
ATRS
2573
DELISTED
Antares Pharma, Inc.
ATRS
| $321K | ﹤0.01% |
118,608
+22,650
| +24% | +$57.5K |
|
|
CDI
2574
DELISTED
CDI Corp.
CDI
| $320K | ﹤0.01% |
22,754
+900
| +4% | +$14.7K |
|
2575
Fresenius Medical Care
FMS
$12.8B
| $319K | ﹤0.01% |
7,703
+963
| +14% | +$37.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.